Sartorius Stedim Biotech stock surges 25% over the quarter
Sartorius Stedim Biotech continues its upward momentum this early afternoon, reaching unprecedented levels for several months in a slightly positive SBF 120. The stock has now accumulated more than 25% over the quarter, one of the sharpest gains among bioprocess values on the Paris exchange.
A rebound of nearly 11% over one month that propels the stock toward its key resistance level
In Tuesday's session, Sartorius Stedim Biotech advances 1.48% to 219.80 €, continuing the breakthrough of the 215.80 € resistance achieved during the Monday September 28 session. The stock is now approaching the next resistance level identified at 223 €, less than 1.5% from the current price. Over one month, gains reached 11.18%, and over the quarter, they exceed 25%.
The price is trading well above its three moving averages: the 20-day MA at 197.04 € (gap of 11.55%), the 50-day MA at 186.40 € (gap of +17.92%) and the 200-day MA at 182.05 €, reflecting an established bullish momentum across multiple timeframes. The RSI at 70 sits at the edge of the overbought zone, signaling a tight configuration without clearly exceeding it: at this stage, buying pressure remains present but leaves little room for additional gains before a potential loss of momentum.
Half-yearly targets confirmed in July, valuation already incorporating the rebound
On the fundamentals side, when publishing first-half 2026 results on July 22, 2026, Sartorius Stedim Biotech confirmed its annual targets, guiding toward revenue of 3,153.8 M€ and EBITDA of 989.2 M€ for the fiscal year. This guidance had then reassured on the bioprocess equipment manufacturer's trajectory, following an extended correction period during preceding quarters. Based on estimates from the analyst consensus surveyed, the stock trades at approximately 44 times the expected earnings for the current fiscal year, and 36.6 times those for the following fiscal year, elevated multiples that reflect sector recovery expectations but already incorporate a significant portion of the recent rebound. The 223 € resistance remains the level to watch for the remainder of the session.
